This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Amir Tchelet: Innovator in Multiple Sclerosis Treatment
Introduction
Amir Tchelet is a notable inventor based in Hod-Hasharon, Israel. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. With a total of 3 patents to his name, Tchelet's work focuses on improving patient outcomes through innovative pharmaceutical methods.
Latest Patents
One of Amir Tchelet's latest patents is titled "Genetic markers predictive of response to glatiramer acetate." This invention provides a method for treating individuals afflicted with multiple sclerosis or those experiencing a single clinical attack consistent with the disease. The method involves using a pharmaceutical composition that includes glatiramer acetate and a pharmaceutically acceptable carrier. The process includes determining single nucleotide polymorphisms (SNPs) that can predict a patient's response to glatiramer acetate.
Another significant patent by Tchelet is also related to glatiramer acetate. It outlines a method for treating patients with multiple sclerosis by identifying whether they are predicted responders to the treatment based on their genotype at specific SNPs. The pharmaceutical composition is administered only if the subject is identified as a predicted responder, ensuring a more personalized approach to treatment.
Career Highlights
Amir Tchelet is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative treatments that can significantly impact the lives of patients suffering from multiple sclerosis.
Collaborations
Throughout his career, Tchelet has collaborated with esteemed colleagues such as Joseph Levy and Colin James Douglas Ross. These partnerships have fostered an environment of innovation and have contributed to the development of effective treatments in the pharmaceutical industry.
Conclusion
Amir Tchelet's contributions to the field of medicine, particularly in the treatment of multiple sclerosis, highlight his role as an influential inventor. His innovative patents and collaborations with other professionals underscore the importance of personalized medicine in improving patient care.